PYRIMETHAMINE - Suchergebnisse

Tansania - Englisch - Tanzania Medicinces & Medical Devices Authority

spaq-co dispersible tablets 250/12.5/76.5

shanghai fosun pharmaceutical development co., ltd, china - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 250/12.5/76.5

Kenia - Englisch - Pharmacy and Poisons Board

s- pyrimac (sulfadoxine and pyrimethamine dispersible tablet

sulfadoxine ph. int. and pyrimethamine ph. int. - dispersible tablet - sulfadoxine ph. int.----500mg pyrimethamine ph.… - pyrimethamine combinations

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

lariam mefloquine 250mg tablets

pharmaco australia ltd - mefloquine hydrochloride, quantity: 274.09 mg (equivalent: mefloquine, qty 250 mg) - tablet, uncoated - excipient ingredients: ammonium alginate; crospovidone; lactose monohydrate; magnesium stearate; microcrystalline cellulose; purified talc; maize starch; poloxamer - malaria treatment: lariam is indicated for the treatment of acute attacks of malaria due to p.falciparum infection resistant to conventional antimalarial drugs. following therapy of mixed p.falciparum/p.vivax malaria with lariam relapse prophylaxis with an 8-aminoquinoline derivative (e.g. primaquine) should be considered in order to eliminate liver forms of p.vivax. malaria prophylaxis: for travellers to countries with documented chloroquine and antifolate combination ( [sulfadoxine/pyrimethamine] / [dapsone/pyrimethamine] ) resistant p.falciparum malaria, who are considered to be at high risk for malaria in view of their residence or travel (of up to 3 months duration) through rural areas (between the dusk to dawn period). for travellers hypersensitive to sulphonamides and sulphones, who are considered to be at high risk for malaria in view of their residence or travel (of up to 3 months duration) through rural areas, (between the dusk to dawn period) in countries with high level chloroquine-resistant p.fal

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

ax pharmaceutical corp- pyrimethamine powder

ax pharmaceutical corp - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) -

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

daraprim- pyrimethamine tablet

tilde sciences llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - treatment of toxoplasmosis: daraprim is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. use of daraprim is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.